acut
lung
injuri
ali
complex
ill
involv
activ
multipl
pathway
lead
lung
injuri
resolut
repair
sinc
first
descript
ali
great
deal
effort
devot
explor
role
individu
pathway
human
anim
model
led
much
greater
understand
complex
ali
link
ali
system
multiorgan
failur
despit
progress
mani
area
still
integr
understand
initi
factor
key
step
progress
ali
central
process
involv
repair
although
anim
model
suggest
rang
new
hypothes
studi
major
need
better
understand
pathway
interact
explain
complex
human
ali
syndrom
complementari
treatment
use
simultan
sequenti
modifi
onset
sever
outcom
ali
human
acut
lung
injuri
ali
sever
form
acut
respiratori
distress
syndrom
ard
syndrom
acut
hypoxem
respiratori
failur
result
varieti
direct
indirect
injuri
ga
exchang
parenchyma
lung
clinic
syndrom
character
critic
hypoxemia
pao
fio
ali
ard
bilater
pulmonari
infiltr
suggest
edema
clinic
measur
evid
cardiac
failur
explan
find
pulmonari
nonpulmonari
infect
sepsi
common
caus
ali
ard
although
gastric
aspir
massiv
transfus
trauma
factor
contribut
divers
caus
stereotyp
physiolog
patholog
respons
made
model
human
ali
ard
difficult
yet
new
theme
evolv
experiment
studi
review
chapter
know
patholog
ali
ard
come
studi
patient
die
although
limit
number
patient
undergon
open
lung
biopsi
figur
patholog
chang
includ
earli
phase
diffus
alveolar
damag
increas
endotheli
permeabl
evid
intravascular
thrombi
sever
epitheli
injuri
denud
alveolar
wall
basement
membran
accumul
protein
fibrinrich
alveolar
infiltr
airspac
abund
alveolar
neutrophil
infiltr
patient
surviv
chang
progress
day
repair
phase
character
hyalin
membran
format
transit
neutrophil
mononuclear
infiltr
appear
intraalveolar
interstiti
fibrosi
patient
surviv
often
persist
hypoxemia
restrict
ventilatori
defect
abnorm
improv
time
hospit
discharg
neuromuscular
weak
rather
respiratori
insuffici
persist
long
term
find
caus
disabl
survivor
ali
ard
caus
factor
precipit
ali
group
broadli
direct
indirect
factor
direct
factor
includ
bacteri
viral
infect
lung
aspir
gastric
content
caus
direct
injuri
airway
alveolar
epithelium
structur
airspac
indirect
factor
includ
system
infect
caus
sepsi
syndrom
blood
transfus
effect
system
medic
illicit
drug
dual
paradigm
plausibl
even
though
clinic
studi
show
major
differ
outcom
patient
direct
vs
indirect
acut
lung
injuri
major
overal
theme
emerg
clinic
studi
human
inher
variabl
respons
stimuli
caus
ali
although
investig
plan
clinic
trial
strive
enrol
uniform
patient
popul
clinician
recogn
patient
seemingli
similar
stimuli
exampl
pneumococc
bacteremia
vari
great
deal
clinic
sever
diseas
studi
normal
peopl
respond
common
bacteri
stimulusgram
neg
lipopolysaccharid
lp
show
differ
order
magnitud
cytokin
respons
whole
blood
studi
normal
human
high
low
respond
bacteri
product
identifi
polymorph
receptor
mark
high
cytokin
respons
gram
posit
bacteri
peptidoglycan
polymorph
common
critic
ill
patient
gram
posit
sepsi
die
thu
studi
variabl
innat
immun
respons
normal
popul
provid
import
insight
diseas
suscept
critic
ill
patient
model
acut
chronic
patholog
chang
ali
order
understand
cellular
molecular
pathogenesi
signific
challeng
time
ard
first
describ
human
mani
differ
anim
model
use
advantag
disadvantag
review
ideal
anim
model
would
includ
acut
inflammatori
respons
increas
microvascular
alveolar
epitheli
permeabl
neutrophil
influx
alveolar
space
protein
fibrin
rich
alveolar
exud
acut
phase
would
follow
organ
phase
increas
alveolar
mononuclear
cell
interstiti
lymphocyt
repair
phase
prolifer
type
ii
pneumocyt
fibroblast
accumul
interstiti
alveolar
fibrin
chang
would
accompani
acut
hypoxemia
fall
lung
complianc
along
measur
chang
system
organ
function
ideal
anim
would
treat
mechan
ventil
simul
primari
treatment
appli
patient
ali
chang
would
evolv
sever
day
surviv
anim
would
amen
longerterm
outcom
studi
assess
persist
chang
lung
function
system
organ
function
particularli
neuromuscular
system
larg
anim
model
permit
studi
ventil
anim
time
ventil
tracheostom
primat
dog
sheep
pig
model
extrem
expens
need
creat
anim
icu
molecular
reagent
larg
anim
limit
short
term
studi
mice
rat
rabbit
use
studi
individu
pathway
generaliz
result
human
limit
nevertheless
characterist
anim
model
well
known
result
interpret
appropri
caution
anim
studi
provid
focus
evalu
key
physiolog
molecular
pathway
use
develop
new
hypothes
test
human
asid
size
import
physiolog
immunolog
differ
exist
among
anim
speci
tabl
intravascular
macrophag
pim
promin
pulmonari
microcircul
sheep
pig
goat
cattl
hors
anim
intravascular
particl
includ
microb
like
local
pulmonari
microcircul
stimul
local
intravascular
inflammatori
respons
dog
rodent
rabbit
nonhuman
primat
human
pim
intravascular
particl
local
macrophag
liver
spleen
deplet
pim
sheep
reduc
lung
injuri
intraven
lp
nitric
oxid
pathway
promot
vasodil
microbi
kill
import
speci
differ
exist
product
induc
nitric
oxid
synthas
promin
rodent
product
import
microbi
kill
mechan
murin
macrophag
human
macrophag
produc
far
less
unless
suitabl
activ
typic
interferon
gamma
nevertheless
product
nitrat
nitrit
evid
nitrat
intracellular
protein
detect
bronchoalveolar
lavag
fluid
alveolar
macrophag
human
ali
suggest
depend
reaction
import
ali
bacteri
recognit
pathway
via
tolllik
receptor
tlr
also
differ
among
speci
diverg
form
recogn
differ
lp
structur
could
contribut
known
variat
lp
sensit
among
differ
speci
one
import
theme
clinic
experiment
ali
activ
innat
immun
advers
affect
lung
respons
mechan
stretch
patient
normal
lung
neuromuscular
diseas
ventil
larg
tidal
volum
exceed
mlkg
without
caus
injuri
experiment
studi
show
normal
tidal
volum
alveolar
wall
rodent
lung
actual
fold
unfold
wherea
alveolar
wall
begin
stretch
lung
volum
exceed
total
lung
capac
contrast
effect
alveolar
volum
injur
lung
much
lower
normal
owe
larg
area
alveolar
fill
collaps
case
use
normal
tidal
volum
result
stretch
wall
open
alveolar
unit
experiment
studi
varieti
system
show
activ
innat
immun
pathway
other
trigger
acut
inflamm
increas
alveolar
epitheli
permeabl
human
alveolar
macrophag
expos
cyclic
pressur
cotreat
lp
caus
mark
accentu
cytokin
respons
pretreat
rat
intraven
lp
accentu
cytokin
inflammatori
respons
lung
ventil
ex
vivo
mechan
ventil
intraven
lp
synergist
effect
lung
inflamm
moder
tidal
volum
via
activ
complex
transcript
pathway
addit
direct
pulmonari
effect
mechan
ventil
intraven
lp
interact
caus
system
organ
dysfunct
relev
pathogenesi
multiorgan
failur
appear
occur
part
enhanc
mediat
signal
pathway
lung
isoform
activ
mek
kinas
lead
activ
map
kinas
jnk
result
enhanc
cytokin
product
mechan
stretch
also
caus
upregul
rabbit
lung
increas
sensit
alveolar
macrophag
lp
ex
vivo
key
coreceptor
lp
increas
express
provid
mechan
synergi
lp
larger
tidal
volum
ventil
interestingli
studi
ventil
mice
smith
et
al
found
synerg
innat
immun
mechan
stretch
appear
acquir
age
occur
wk
old
mice
reproduc
present
wk
old
mice
activ
innat
immun
also
present
lung
patient
ali
seri
studi
shown
endogen
product
gener
injuri
inflammatori
respons
caus
steril
inflamm
bacteri
product
absent
product
term
alarmin
dangerassoci
molecular
pattern
damp
includ
matrix
molecul
hyaluronan
nuclear
protein
oxid
phospholipid
factor
present
normal
lung
releas
airspac
result
injuri
inflamm
endogen
product
activ
tlr
initi
inflamm
manner
lp
bacteri
product
implic
endogen
molecul
also
synerg
mechan
stretch
intensifi
injuri
lung
one
primari
suggest
line
research
interrupt
synergist
interact
innat
immun
mechan
stretch
lung
new
strategi
could
limit
onset
sever
ali
human
death
alveolar
epithelium
ali
occur
either
necrosi
apoptosi
classic
studi
bachofen
weibel
examin
lung
patient
die
ali
show
evid
widespread
alveolar
epitheli
injuri
addit
alveolar
hyalin
membran
microvascular
injuri
thrombosi
experiment
studi
shown
high
distend
pressur
caus
mechan
ventil
lead
directli
disrupt
necrosi
alveolar
epithelium
rat
addit
type
iii
bacteri
exotoxin
pseudomona
exou
exo
caus
direct
lysi
alveolar
epithelium
cell
attack
cell
membran
disrupt
alveolar
epithelium
mechan
stretch
treat
reduc
ventil
tidal
volum
like
explain
part
major
success
initi
ard
network
trial
low
tidal
volum
ventil
ali
necrosi
regul
manipul
cellular
pathway
strategi
minim
necrosi
must
aim
prevent
lower
tidal
volum
erad
bacteri
infect
apoptosi
regul
form
cell
death
essenti
role
develop
repair
import
theme
experiment
studi
cell
death
pathway
activ
lung
patient
ali
like
contribut
alveolar
epitheli
death
apoptosi
mediat
famili
death
receptor
princip
tnf
receptor
fa
receptor
abund
bronchoalveolar
lavag
bal
fluid
patient
ali
concentr
solubl
tnf
receptor
far
exce
concentr
free
suggest
tnf
activ
exist
local
lung
tissu
fa
receptor
present
alveolar
airway
epithelium
biolog
activ
solubl
fa
ligand
sfasl
detect
airspac
patient
ali
experiment
studi
activ
fa
receptor
lung
mice
caus
alveolar
epitheli
apoptosi
increas
epitheli
permeabl
alveolar
hemorrhag
rabbit
mice
rabbit
activ
fa
also
caus
inflamm
product
acut
inflammatori
cytokin
repeat
activ
fa
mice
caus
acut
inflamm
acut
increas
alveolar
epitheli
permeabl
delay
fibrosi
depend
macrophag
metalloelastas
studi
chimer
anim
shown
fa
nonmyeloid
cell
lung
requir
apoptosi
inflamm
occur
respons
fa
activ
sfasl
molecul
releas
cell
membran
via
action
membran
like
sfasl
multimer
aqueou
solut
multimer
form
cluster
fa
receptor
cell
membran
cluster
fa
molecul
recruit
molecul
intracellular
portion
fa
molecul
form
death
induc
complex
disc
cluster
autocatalyt
yield
cleav
initi
caspas
cascad
lead
fragment
nuclear
dna
receptormedi
apoptosi
biolog
activ
sfasl
depend
structur
ntermin
sequenc
molecul
state
aggreg
oxid
key
methionin
residu
promot
aggreg
sfasl
solut
enhanc
biolog
activ
free
cleav
stalk
region
reduc
biolog
activ
intens
oxid
environ
concentr
solubl
regul
biolog
activ
sfasl
vivo
mice
lack
activ
fa
receptor
lpr
mice
reduc
lung
inflamm
undergo
larg
volum
mechan
ventil
inactiv
fa
signal
normal
mice
use
sirna
technolog
reduc
secondari
lung
injuri
respons
hemorrhag
shock
cecal
ligat
punctur
suggest
fa
pathway
lung
connect
system
respons
alveolar
inflamm
epitheli
injuri
data
support
theme
fasmedi
alveoli
epitheli
apoptosi
like
import
acut
lung
injuri
process
human
turn
suggest
strategi
inhibit
apoptosi
lung
might
use
limit
sever
ali
human
apoptosi
also
import
resolut
injuri
tissu
repair
process
initi
onset
ali
human
strategi
modul
cellular
apoptosi
would
focus
earli
phase
ali
order
avoid
interf
normal
repair
lung
transform
growth
factor
beta
pleuripot
cytokin
key
role
tissu
homeostasi
latent
form
activ
bound
integrin
lung
skin
mice
lack
integrin
protect
lung
injuri
follow
intratrach
bleomycin
mice
treat
construct
protect
lung
injuri
caus
bleomycin
lp
enhanc
epitheli
permeabl
vitro
part
deplet
intracellular
glutathion
subsequ
studi
show
reduc
express
epitheli
sodium
channel
enac
reduc
sodium
water
transport
across
rat
human
type
ii
alveolar
epitheli
cell
reduc
amilorid
sensit
sodium
transport
intact
rat
lung
low
dose
affect
alveolar
epitheli
permeabl
anim
studi
suggest
activ
lung
patient
ali
could
mechan
contribut
epitheli
injuri
impair
sodium
water
transport
alveolar
space
strategi
inhibit
transient
might
consid
human
ali
anim
model
ali
ard
use
primarili
studi
singl
pathway
involv
lung
injuri
treatment
design
inhibit
singl
pathway
unsuccess
patient
sepsi
well
ali
advanc
proteom
genom
technolog
enabl
investig
appreci
complex
ali
human
well
anim
model
human
analysi
protein
human
bal
fluid
show
complex
protein
network
onset
ali
chang
occur
time
key
node
network
identifi
central
protein
could
provid
target
new
treatment
addit
proteom
analysi
identifi
unsuspect
import
nonprotein
betaestradiol
node
protein
network
gene
array
technolog
illustr
complex
mrna
network
canin
model
ventilatorinduc
lung
injuri
gene
involv
inflamm
immun
respons
cell
prolifer
adhes
signal
apoptosi
activ
lung
major
region
differ
note
depend
nondepend
area
approach
provid
addit
support
role
apoptosi
pathway
ali
genom
approach
also
use
studi
complex
transcript
respons
mice
treat
mechan
ventil
without
system
lp
integr
gene
express
profil
gene
ontolog
promot
analysi
enabl
construct
regulatori
map
import
process
lung
ventil
anim
presenc
absenc
lp
simultan
activ
innat
immun
figur
differenti
express
biolog
modul
includ
relat
defens
respons
immun
respons
oxidoreductas
activ
gene
regulatori
network
includ
transcript
factor
ifnstimul
respons
element
tabl
studi
highlight
complex
lung
respons
experiment
anim
ali
set
stage
strategi
address
multipl
pathway
simultan
sequenti
critic
ill
human
anim
model
provid
new
understand
sever
risk
factor
ali
includ
pathogenesi
ali
follow
gastric
aspir
transfus
blood
product
role
chronic
alcohol
use
fever
aspir
gastric
content
expos
airway
alveolar
environ
complex
mixtur
acid
particul
oropharyng
bacteria
bacteri
product
classic
model
acid
aspir
anim
involv
intratrach
instil
acid
typic
ph
caus
acut
lung
injuri
inflamm
product
proinflammatori
cytokin
howev
human
routin
treat
antagonist
andor
proton
pump
inhibitor
ph
gastric
acid
typic
much
higher
patient
less
acid
solut
injur
lung
anim
bregeon
associ
sampl
gastric
juic
critic
ill
patient
studi
proinflammatori
activ
use
valid
target
cell
assay
gastric
juic
critic
ill
patient
proinflammatori
activ
detect
gastric
juic
ventil
control
patient
sampl
high
proinflammatori
activ
vitro
caus
intens
lung
inflamm
lung
ventil
rabbit
depend
activ
gastric
juic
independ
ph
particul
matter
help
explain
intens
sometim
transient
inflammatori
respons
associ
gastric
aspir
patient
treat
antiacid
regimen
transfus
red
blood
cell
platelet
high
volum
plasma
blood
product
known
associ
transfus
reaction
lead
sever
transfus
associ
lung
injuri
trali
anim
model
show
prime
event
administr
intraven
intratrach
lp
usual
requir
lung
injuri
consist
observ
trali
common
human
critic
ill
interact
antibodi
leukocyt
platelet
typic
involv
lipid
mediat
plasma
also
implic
one
model
passiv
infus
antibodi
led
trali
depend
fcgamma
receptor
neutrophil
platelet
interestingli
mice
rais
barrier
facil
less
suscept
pretreat
mice
either
intraven
intratrach
lp
restor
suscept
studi
chimer
mice
show
function
leukocyt
requir
effect
increas
pmn
trap
lung
microcircul
superoxid
product
respons
stimuli
thu
appear
key
role
activ
innat
immun
via
perhap
tlr
enhanc
suscept
trali
anim
clinic
studi
contribut
understand
mechan
chronic
alcohol
ingest
increas
suscept
lung
injuri
rat
fed
high
alcohol
diet
total
calori
develop
glutathion
deplet
epitheli
line
fluid
lung
reduc
sodium
water
transport
vivo
glutathion
major
intracellular
pathway
captur
oxid
speci
glutathion
deplet
render
lung
tissu
suscept
oxid
injuri
glutathion
deplet
type
ii
pneumocyt
rat
fed
high
alcohol
diet
type
ii
monolay
increas
permeabl
high
molecular
weight
solut
experiment
observ
parallel
find
clinic
stabl
peopl
ingest
alcohol
chronic
basi
reduc
concentr
glutathion
alveolar
epitheli
line
fluid
increas
suscept
lung
injuri
fever
benefici
host
respons
bacteri
infect
mani
patient
ali
treat
antibiot
regimen
overt
bacteri
infect
lung
fever
improv
outcom
mice
periton
model
infect
fever
also
worsen
respons
lung
hyperoxia
local
klebsiella
infect
part
enhanc
neutrophil
recruit
lipk
et
al
found
fever
dramat
effect
innat
immun
lung
induct
fever
mice
treat
low
dose
lp
stimul
caus
dramat
increas
mortal
associ
induct
apoptosi
pathway
lung
find
drive
better
clinic
studi
effect
fever
patient
major
microbi
infect
one
interest
theme
anim
studi
mesenchym
stem
cell
modul
ali
mesenchym
stem
cell
msc
popul
progenitor
cell
abil
selfrenew
undifferenti
state
differenti
mesenchym
tissu
bone
fat
smooth
muscl
collagen
msc
known
exist
mononuclear
cell
fraction
bone
marrow
defin
densiti
gradient
centrifug
intern
societi
cellular
therapi
propos
follow
criteria
defin
multipot
stromal
mesenchym
cell
adhes
plastic
b
express
lack
express
hladr
surfac
molecul
c
abil
differenti
osteoblast
adipocyt
chondroblast
vitro
initi
studi
investig
role
bone
marrowderiv
msc
bmmsc
pulmonari
fibrosi
focus
hypothesi
bmmsc
could
protect
regener
injur
lung
tissu
semin
studi
ortiz
et
al
found
bleomycininduc
lung
injuri
decreas
mice
receiv
intraven
inject
bmmsc
purifi
bleomycinresist
balbc
mice
compar
mice
receiv
bmmsc
protect
effect
occur
bmmsc
given
immedi
bleomycin
challeng
cell
administ
day
bleomycin
subsequ
studi
suggest
bleomycin
induc
mobil
bmmsc
bone
marrow
possibl
migrat
lung
studi
suggest
bmmsc
engraft
lung
differenti
varieti
cell
type
howev
subsequ
studi
shown
engraft
occur
rare
physiolog
signific
remain
uncertain
despit
signific
engraft
msc
administr
varieti
injuri
model
associ
decreas
express
sever
inflammatori
cytokin
lead
hypothesi
bmmsc
abl
modul
inflammatori
respons
gupta
et
el
confirm
immunomodulatori
properti
bmmsc
vivo
demonstr
direct
intratrach
instil
bmmsc
attenu
lpsinduc
lung
injuri
mechan
involv
paracrin
effect
unrel
tissu
regener
later
studi
ortiz
et
al
suggest
protect
effect
bmmsc
bleomycininduc
lung
injuri
larg
relat
abil
bmmsc
releas
antagonist
sinc
sever
studi
shown
bmmsc
attenu
injuri
differ
experiment
anim
model
review
thu
bmmsc
attenu
lung
injuri
immunomodul
major
studi
publish
thu
far
suggest
protect
role
role
msc
lung
inflamm
fibrosi
subject
separ
review
human
studi
shown
repair
process
initi
almost
soon
ali
begin
marker
collagen
product
reflect
activ
repair
process
detect
onset
ali
great
deal
work
devot
determin
neutrophil
product
clear
inflam
lung
isol
neutrophil
rapidli
undergo
apoptosi
vitro
lung
fluid
patient
ali
delay
neutrophil
apoptosi
mechan
involv
gcsf
gmcsf
lung
fluid
apoptot
neutrophil
rapidli
ingest
macrophag
airspac
via
recognit
phosphatidyl
serin
calreticulin
structur
express
surfac
apoptot
leukocyt
neutrophil
myeloperoxidas
debri
identifi
alveolar
macrophag
recov
bal
fluid
patient
ali
mechan
control
uptak
clearanc
leukocyt
cell
undergo
necrosi
nonapoptot
cell
death
less
well
understood
new
theme
anim
studi
lymphocyt
also
import
role
resolut
ali
studi
mice
lack
matur
b
cell
show
resolut
lp
induc
lung
inflamm
markedli
delay
mortal
higher
mice
remain
clinic
ill
longer
period
time
similarli
treat
mice
reconstitut
mice
regulatori
cell
express
receptor
transcript
factor
treg
improv
resolut
lung
injuri
treg
increas
time
onset
lpsinduc
lung
inflamm
normal
mice
transfer
treg
mice
increas
lung
level
enhanc
neutrophil
apoptosi
follow
anim
studi
investig
found
treg
detect
flow
cytometri
lung
lavag
fluid
patient
ali
manipul
regulatori
cell
could
offer
approach
enhanc
repair
ali
consist
theme
anim
studi
clinic
manifest
viral
infect
lung
reflect
primari
site
infect
lung
adenovirus
infect
primarili
airway
epithelium
via
receptor
basolater
surfac
airway
epitheli
cell
featur
made
replic
defici
adenovir
vector
attract
gene
therapi
lung
adenovir
infect
character
bronchopneumonia
sever
lead
acut
respiratori
failur
studi
nonhuman
primat
show
sar
viru
attack
alveolar
type
ii
cell
sar
associ
diffus
lung
injuri
reflect
alveolar
epitheli
damag
contrast
hantaviru
found
lung
microvascular
endotheli
cell
caus
widespread
lung
edema
soon
onset
infect
addit
theme
anim
studi
viral
infect
also
enhanc
sensit
lung
mechan
ventil
bem
et
al
found
mice
infect
mous
pneumoviru
simul
respiratori
syncyti
viru
rsv
infect
children
much
sever
lung
inflammatori
injuri
respons
mice
infect
pneumoviru
alon
mice
treat
mechan
ventil
alon
infect
mice
increas
cytokin
product
increas
alveolar
epitheli
permeabl
activ
apoptosi
pathway
suggest
key
treatment
children
sever
rsv
infect
mechan
ventil
worsen
respons
lung
underli
viral
infect
virus
stimul
innat
immun
interact
surfac
macrophag
cell
support
conclus
activ
innat
immun
via
number
differ
tlr
synergist
effect
mechan
ventil
lung
injuri
one
theme
clinic
studi
ali
less
frequent
less
sever
children
adult
even
though
mortal
unselect
children
ali
approxim
children
lung
still
develop
typic
fewer
comorbid
adult
ali
nevertheless
new
theme
anim
studi
interact
mechan
ventil
lung
children
might
differ
adult
smith
et
al
compar
pulmonari
respons
juvenil
wk
gm
adult
wk
gm
mice
model
mice
treat
intratrach
lp
subject
mechan
ventil
four
hour
adult
mice
synergist
increas
lung
inflamm
protein
permeabl
compar
anim
treat
lp
alon
mechan
ventil
alon
contrast
synergist
interact
lp
treatment
mechan
ventil
found
juvenil
mice
suggest
advers
interact
innat
immun
mechan
stretch
increas
age
microarray
studi
show
major
differ
cluster
gene
activ
juvenil
adult
lung
respons
lp
mechan
ventil
suggest
pathway
might
respons
differ
respons
juvenil
adult
alvira
associ
treat
neonat
adult
mice
intraperiton
lp
found
lung
inflamm
apoptosi
occur
adult
neonat
mice
associ
persist
activ
nfkappab
heterodim
neonat
wherea
adult
initi
activ
nfkappab
follow
sustain
activ
nfkappab
homodim
development
differ
nfkappab
activ
could
influenc
sever
outcom
pulmonari
infect
pulmonari
respons
mechan
ventil
studi
compar
infant
adult
anim
could
provid
much
better
perspect
mechan
account
protect
ali
children
increas
suscept
adult
acut
lung
injuri
import
clinic
problem
affect
peopl
per
year
unit
state
anim
model
use
studi
individu
pathway
involv
pathogenesi
new
idea
treatment
singl
anim
model
mimic
clinic
featur
ali
human
anim
model
uniqu
featur
affect
respons
treatment
nevertheless
mani
theme
emerg
anim
model
provid
valuabl
insight
lung
injuri
human
studi
innat
immun
shown
innat
immun
trigger
bacteri
product
also
endogen
byproduct
tissu
damag
inflamm
drive
inflamm
even
absenc
microbi
product
tissu
variabl
host
innat
immun
respons
account
great
deal
variabl
clinic
manifest
ali
innat
immun
mechan
stretch
import
synergist
interact
adult
accentu
ali
synergist
interact
appear
acquir
age
much
less
pronounc
juvenil
anim
apoptosi
pathway
import
clearanc
bacteria
lung
also
caus
injuri
death
alveolar
epitheli
cell
enhanc
permeabl
edema
anim
model
highlight
complex
ali
human
show
multipl
pathway
activ
microbi
product
mechan
stretch
combin
analysi
put
network
identifi
unexpect
compon
link
key
protein
pathway
lung
new
light
shed
clinic
risk
factor
ali
gastric
aspir
blood
product
transfus
alcohol
excess
fever
field
stem
cell
biolog
extend
ali
find
unexpect
paracrin
effect
mesenchym
stem
cell
reduc
sever
ali
new
idea
resolut
ali
deriv
studi
clearanc
apoptot
cell
lung
role
regulatori
lymphocyt
recoveri
lung
inflamm
injuri
progress
made
continu
need
strong
link
laboratori
critic
care
bedsid
order
translat
new
idea
laboratori
studi
clinic
treatment
lessen
sever
improv
outcom
ali
modular
regulatori
map
import
process
transcript
factor
identifi
acut
lung
injuri
mice
treat
intratrach
lp
mechan
ventil
overrepres
biolog
modul
among
upregul
red
oval
downregul
blue
oval
gene
organ
base
gene
ontolog
annot
assign
one
three
group
molecular
function
cellular
compon
biolog
process
put
transcript
factor
regul
gene
within
modul
shown
peripheri
refer
permiss
tabl
enrich
transcript
factor
among
differenti
express
gene
mv
lp
mvlp
rel
untreat
anim
crit
care
clin
author
manuscript
avail
pmc
juli
